Charles Schwab Investment Management Inc Poseida Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 567,063 shares of PSTX stock, worth $1.54 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

567,063

Previous 545,808 3.89%

Holding current value

$1.54 Million

Previous $1.59 Million 1.76%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$2.7 - $4.04 $57,388 - $85,870	21,255 Added 3.89%	567,063 $1.62 Million
Q2 2024 Aug 12, 2024	BUY	$2.0 - $3.46 $26,430 - $45,723	13,215 Added 2.48%	545,808 $1.59 Million
Q1 2024 May 08, 2024	BUY	$2.76 - $4.13 $63,010 - $94,287	22,830 Added 4.48%	532,593 $1.7 Million
Q4 2023 Feb 06, 2024	BUY	$1.83 - $3.51 $12,237 - $23,471	6,687 Added 1.33%	509,763 $1.71 Million
Q3 2023 Nov 08, 2023	BUY	$1.62 - $2.79 $119,070 - $205,065	73,500 Added 17.11%	503,076 $1.2 Million
Q2 2023 Aug 09, 2023	BUY	$1.66 - $3.4 $280,257 - $574,022	168,830 Added 64.75%	429,576 $756,000
Q1 2023 May 11, 2023	SELL	$3.08 - $8.73 $11,799 - $33,444	-3,831 Reduced 1.45%	260,746 $803,000
Q4 2022 Feb 13, 2023	BUY	$3.33 - $6.38 $17,602 - $33,724	5,286 Added 2.04%	264,577 $1.4 Million
Q3 2022 Nov 14, 2022	BUY	$2.43 - $4.51 $308,298 - $572,192	126,872 Added 95.81%	259,291 $916,000
Q2 2022 Aug 15, 2022	SELL	$1.87 - $5.0 $163,944 - $438,355	-87,671 Reduced 39.83%	132,419 $342,000
Q1 2022 May 13, 2022	BUY	$3.22 - $7.04 $26,819 - $58,636	8,329 Added 3.93%	220,090 $987,000
Q4 2021 Feb 11, 2022	BUY	$6.23 - $7.6 $17,605 - $21,477	2,826 Added 1.35%	211,761 $1.44 Million
Q3 2021 Nov 16, 2021	BUY	$7.09 - $10.71 $573,368 - $866,117	80,870 Added 63.15%	208,935 $1.52 Million
Q2 2021 Aug 16, 2021	SELL	$7.96 - $10.07 $107,069 - $135,451	-13,451 Reduced 9.5%	128,065 $1.28 Million
Q1 2021 May 17, 2021	BUY	$8.51 - $11.91 $442,843 - $619,772	52,038 Added 58.16%	141,516 $1.35 Million
Q4 2020 Feb 16, 2021	BUY	$8.29 - $11.7 $12,434 - $17,550	1,500 Added 1.7%	89,478 $982,000
Q3 2020 Nov 13, 2020	BUY	$8.09 - $16.25 $711,742 - $1.43 Million	87,978 New	87,978 $781,000

Others Institutions Holding PSTX

# of Institutions

Shares Held

38.5M

Call Options Held

377K

Put Options Held

22.2K

View Full List

About Poseida Therapeutics, Inc.

Ticker PSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 85,775,600
Market Cap $232M
Description
Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...

More about PSTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Poseida Therapeutics, Inc. Transaction History